arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

AVANOS MEDICAL, INC.

AVNS
$24.99 0.00 (0.00%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
54 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
36
Health
Weak
Moderately Bearish
auto_awesome

Analytical Summary

AVANOS MEDICAL, INC. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). On the positive side, Debt to Equity remains strong. Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $1.2B
Dividend Yield —
Revenue Growth 8.8% ↗
Op. Margin 4.9% ↗
ROIC 0.7% ↗
FCF / Share $-0.26
Trailing P/E 227.2x
Price / Book 1.5x
FCF Yield —
Debt / Equity 0.11
info Valuation on last close. End-of-day price, Jul 24, 2026.

54-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$182.20M
↑ +8.8% —
Net Income Profit after all expenses
$5.10M
↓ -22.7% —
Operating Margin Operating profit as % of sales
4.9%
↑ +253.5% 16th
FCF / Share Free cash flow per share
$-0.26
↓ -187.7% —
Long-Term Debt Long-term obligations
$87.30M
↓ -3.3% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
32
Returns
35
Financial Health ↑
56
Cash Quality
10

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 15 years · 54 quarters